🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

313,52 USD

Máx. histórico

322,75

4 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-2,86%

Rango 52 semanas

175,89 – 326,63

Variación hoy

+2,12%

Cierre anterior

307,02

Rango de hoy

309,46 – 317,76

Volumen hoy

195.564

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
33,04 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 4 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/06/1993 36,49 36,49 36,49 36,49 +8,33% 0,00% 1.763
18/06/1993 33,69 33,69 33,69 33,69 +2,86% 0,00% 347
17/06/1993 32,75 36,49 32,75 32,75 -10,26% 11,43% 240
16/06/1993 33,69 36,49 32,75 36,49 +11,43% 11,11% 2.271
15/06/1993 32,75 33,69 32,75 32,75 -4,11% 2,86% 3.340
14/06/1993 32,75 35,56 32,75 34,15 -3,95% 8,57% 748
11/06/1993 35,56 35,56 32,75 35,56 +0,00% 7,89% 214
10/06/1993 33,69 35,56 32,75 35,56 +0,00% 8,33% 16.751
09/06/1993 33,69 35,56 33,69 35,56 +2,70% 5,56% 2.137
08/06/1993 34,62 36,03 33,69 34,62 +0,00% 6,76% 1.843
07/06/1993 35,56 37,43 34,62 34,62 -2,63% 7,89% 1.095
04/06/1993 37,43 38,37 35,56 35,56 -5,00% 7,50% 5.423
03/06/1993 39,30 39,30 37,43 37,43 +0,00% 4,76% 2.217
02/06/1993 39,30 39,30 37,43 37,43 -4,76% 4,76% 214
01/06/1993 39,30 39,30 39,30 39,30 +5,00% 0,00% 214
28/05/1993 37,43 37,90 37,43 37,43 -4,76% 1,25% 20.625
27/05/1993 39,30 39,30 37,43 39,30 +0,00% 4,76% 347
26/05/1993 39,30 39,30 37,43 39,30 +0,00% 4,76% 3.153
25/05/1993 37,43 39,30 37,43 39,30 +5,00% 5,00% 2.618
24/05/1993 37,43 40,24 37,43 37,43 +0,00% 7,50% 5.477
21/05/1993 37,43 38,37 37,43 37,43 +0,00% 2,50% 3.500
20/05/1993 37,43 40,24 37,43 37,43 -6,98% 7,50% 401
19/05/1993 39,30 40,24 37,43 40,24 +1,18% 7,14% 4.836
18/05/1993 32,75 40,24 32,75 39,77 +18,06% 22,86% 13.412
17/05/1993 32,75 35,56 32,75 33,69 +2,86% 8,57% 3.446
14/05/1993 32,75 35,56 32,75 32,75 -4,11% 8,57% 1.496
13/05/1993 32,75 35,56 32,75 34,15 -3,95% 8,57% 7.962
12/05/1993 35,56 35,56 32,75 35,56 +5,56% 7,89% 1.363
11/05/1993 35,56 35,56 32,75 33,69 -5,26% 7,89% 1.550
10/05/1993 32,75 35,56 32,75 35,56 +5,56% 8,57% 481